Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Ross

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Cell Death & Disease|June 12, 2024
Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemiaGus O Nwosu, David M Ross, Jason A Powell, et al.
Pathology|March 19, 2022
Flow cytometric monocyte repartition demonstrates overlap between chronic myelomonocytic leukaemia and myeloid neoplasms with monocytosisSharon A Allen, Eugene Ng, Uwe H Hahn, et al.
Cancers|September 27, 2025
Lipid Storage and Therapy Resistance in Chronic Myeloid Leukaemia: A Novel Perspective on Targeting Metabolic VulnerabilitiesMolly Tolland, David M Ross, Deborah White, et al.
American Journal of Hematology|January 22, 2019
Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014Peter D Baade, David M Ross, Lesley A Anderson, et al.
Obstetric Medicine|April 15, 2020
Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: Two case reports with maternal and fetal outcomes and literature reviewSu J Chua, Mark R Morton, John Svigos, et al.
Pathology|September 18, 2021
Spatial disparities in the reported incidence and survival of myeloproliferative neoplasms in AustraliaJessica Katherine Cameron, Lin Fritschi, David M Ross, et al.
Leukemia Research|September 24, 2024
Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypesJonathan Lim, David M Ross, Anna L Brown, et al.
Cancer Genetics and Cytogenetics|February 14, 2009
Genomic translocation breakpoint sequences are conserved in BCR-ABL1 cell lines despite the presence of amplificationDavid M Ross, Lisa Schafranek, Timothy P Hughes, et al.
Blood Neoplasia|December 22, 2025
Do all patients with chronic phase CML require a diagnostic bone marrow biopsy in the modern TKI era?Noel F T Fong, David M Ross, David T Yeung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2018
Management of Pregnancy in Women With Chronic Myeloid LeukemiaDavid M Ross, Kate L Burbury, Andrew P Grigg, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Cell Death & Disease|June 12, 2024
Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemiaGus O Nwosu, David M Ross, Jason A Powell, et al.
Pathology|March 19, 2022
Flow cytometric monocyte repartition demonstrates overlap between chronic myelomonocytic leukaemia and myeloid neoplasms with monocytosisSharon A Allen, Eugene Ng, Uwe H Hahn, et al.
Cancers|September 27, 2025
Lipid Storage and Therapy Resistance in Chronic Myeloid Leukaemia: A Novel Perspective on Targeting Metabolic VulnerabilitiesMolly Tolland, David M Ross, Deborah White, et al.
American Journal of Hematology|January 22, 2019
Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014Peter D Baade, David M Ross, Lesley A Anderson, et al.
Obstetric Medicine|April 15, 2020
Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: Two case reports with maternal and fetal outcomes and literature reviewSu J Chua, Mark R Morton, John Svigos, et al.
Pathology|September 18, 2021
Spatial disparities in the reported incidence and survival of myeloproliferative neoplasms in AustraliaJessica Katherine Cameron, Lin Fritschi, David M Ross, et al.
Leukemia Research|September 24, 2024
Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypesJonathan Lim, David M Ross, Anna L Brown, et al.
Cancer Genetics and Cytogenetics|February 14, 2009
Genomic translocation breakpoint sequences are conserved in BCR-ABL1 cell lines despite the presence of amplificationDavid M Ross, Lisa Schafranek, Timothy P Hughes, et al.
Blood Neoplasia|December 22, 2025
Do all patients with chronic phase CML require a diagnostic bone marrow biopsy in the modern TKI era?Noel F T Fong, David M Ross, David T Yeung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2018
Management of Pregnancy in Women With Chronic Myeloid LeukemiaDavid M Ross, Kate L Burbury, Andrew P Grigg, et al.
Pageof 13